Mahindra Manulife
Flexi Cap Fund


(An open ended dynamic equity scheme investing
across large cap, mid cap, small cap stocks)



One Pager as on August 31, 2023

 
Flexibility to invest in opportunities across market capitalization
 
Bottom up stock selection process
 
Active allocation across Market capitalization based on macro-economic indicators, policy environment, valuations, market conditions
 
Top down approach to select sectors
 
Management through diversification of holdings and disciplined approach to monitor individual stock position based on market capitalization
 
The Scheme follows top down sector allocation and bottom up stock selection ideas that may benefit based on health of economy. Allocation across marketcaps is a function of economic outlook, domestic liquidity and stage of market cycle. Focus will be on high quality, growth focused companies available at reasonable valuations.
  • Key Overweight sector/Industries includes Consumer Durables, Capital Goods and Banks sector vs the Scheme’s Benchmark. Reduced the OW in Insurance post the Union Budget announcements

  • Key Underweights sectors /Industries includes Oil & Gas, FMCG and Healthcare vs the Scheme’s Benchmark

  • Portfolio is gradually shifting to small caps where the earnings have triggers and valuations comfortable
Sector MMFCF Nifty 500 Index TRI
Financial Services 31.92% 31.16%
Information Technology 11.56% 10.32%
Capital Goods 7.82% 4.75%
Consumer Durables 7.42% 3.67%
Automobile And Auto Components 6.77% 6.21%

Data as on August 31, 2023

Security % to Net Assets
HDFC Bank Limited 8.86%
ICICI Bank Limited 7.25%
Infosys Limited 5.97%
Reliance Industries Limited 5.07%
Tata Consultancy Services Limited 3.84%
Axis Bank Limited 3.55%
Larsen & Toubro Limited 3.16%
Bajaj Finance Limited 2.70%
Maruti Suzuki India Limited 2.70%
Hindustan Unilever Limited 2.66%
Total 45.74%
Fresh Additions Complete Exits
Security Security
Coforge Limited APL Apollo Tubes Limited
Sumitomo Chemical India Limited Century Plyboards (India) Limited
Voltas Limited Narayana Hrudayalaya Limited
- Zydus Lifesciences Limited


Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/ sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on August 31, 2023

Turnover Ratio (Last 1 year) 0.66
Investment Objective:
The investment objective of the Scheme is to generate long term capital appreciation by investing in a diversified portfolio of equity and equity-related securities across market capitalization. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Fund Manager:

Ms. Fatema Pacha
Total Experience : 18 years
Experience in managing this fund: 2 years (Managing since August 23, 2021)

Mr. Manish Lodha
Total Experience : 23 years,
Experience in managing this fund: 2 years (Managing since August 23, 2021)

Date of allotment: August 23, 2021

Benchmark: Nifty 500 Index TRI

Option: Growth; IDCW

IDCW Sub-options: IDCW Reinvestment & IDCW Payout

Minimum Application Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter

Minimum Redemption/Switch-Out Amount: Rs. 1,000/- or 100 units or account balance, whichever is lower

Minimum Weekly & Monthly SIP Amount: : Rs 500 and in multiples of Re. 1 /- thereafter

Minimum Weekly & Monthly SIP Installments: 6

Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re. 1/- thereafter

Minimum Quarterly SIP installments: 4

Monthly AAUM as on August 31, 2023 (Rs. in Cr.): 1,029.51

Monthly AUM as on August 31, 2023 (Rs. In Cr.): 1,038.72

Entry Load: Not applicable

Exit Load: 0.1%*
  • An Exit Load of 1% is payable if Units are redeemed / switched-out upto 3 months from the date of allotment;
  • Nil if Units are redeemed / switched-out after 3 months from the date of allotment.

^Benchmark ^^Additional Benchmark. Inception/Allotment date: 23-Aug-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 23-August-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).

^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha manage 10 schemes and Ms. Fatema Pacha
manage 8 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided. Performance as on August 31, 2023

Scheme Name
Mahindra Manulife Flexi Cap Fund

This product is suitable for investors who are seeking*:
• Long term capital appreciation.
• Investment in diversified portfolio of equity & equity related instruments across market capitalization

Scheme Riskometer

Scheme Benchmark
Nifty 500 Index TRI

Benchmark Riskometer

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Investment Management Private Limited nor Mahindra Manulife Trustee Private Limited, its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Get in Touch: Unit No. 204, 2nd Floor, Amiti Building, Piramal Agastya Corporate Park, LBS Road, Kamani Junction, Kurla (W), Mumbai – 400 070.
Phone: +91-22-66327900, Fax: +91-22-66327932
Toll Free No.: 1800 419 6244
Website: www.mahindramanulife.com

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
CNo.01290